Whitehawk Therapeutics, Inc. Ratios

Ratios Dec2010 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 91.23%88.47%88.36%
EBT Margin 1,187.43%550.16%488.36%451.14%372.78%396.64%-51.61%-24.83%-786.34%-397.69%-270.04%-245.13%
EBIT Margin 1,087.43%450.16%388.36%351.14%272.78%296.64%-55.47%-18.21%-794.41%-411.94%-295.36%-259.62%
EBITDA Margin 1,087.43%450.16%388.36%351.14%272.78%296.64%-55.47%-31.89%-790.98%-398.45%-269.45%-245.17%
Operating Margin 1,087.43%450.16%388.36%351.14%272.78%296.64%-55.47%-18.21%-794.41%-411.94%-295.36%-259.62%
Net Margin 1,187.43%550.16%488.36%451.14%372.78%396.64%-51.58%-30.82%-790.98%-397.69%-270.04%-245.13%
FCF Margin 1,020.36%492.92%396.87%234.66%257.70%159,237.99%-29.00%-90.86%-160.49%-329.15%-261.29%-235.55%
Efficiency
Inventory Average 4.14M5.87M
Assets Average 52.03M29.38M88.37M171.07M158.33M101.37M
Equity Average 47.60M12.05M61.99M147.39M131.79M78.84M
Invested Capital 58.67M36.54M1.88M136.66M158.38M105.19M52.48M
Asset Utilization Ratio 0.480.160.090.150.26
Leverage & Solvency
Interest Coverage Ratio -10.87-4.50-3.88-3.51-2.73-2.97-3.13-167.24-272.53-311.40-438.04
Debt to Equity -1.150.04
Debt Ratio 0.760.04
Equity Ratio 0.910.91-0.660.860.860.790.75
Times Interest Earned -10.87-4.50-3.88-3.51-2.73-2.97-3.13-167.24-272.53-311.40-438.04
Dividends & Payouts
FCF Payout Ratio -0.20
Valuation
Enterprise Value 6.39M-13.22M41.71M355.60M140.43M-59.30M30.53M
Market Capitalization 69.00M25.31M46.17M504.59M312.99M49.54M77.76M
Return Ratios
Return on Sales 11.87%5.50%4.88%4.51%3.73%3.97%-0.52%-0.25%-7.86%-3.98%-2.70%-2.45%
Return on Capital Employed -0.50%3.76%-1.52%-0.41%-0.55%-0.80%
Return on Assets -0.45%-0.12%-1.25%-0.35%-0.42%-0.63%
Return on Equity -0.49%-0.29%-1.78%-0.41%-0.50%-0.81%